Related Experiment Video
Updated: May 5, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors
Ashwin A Dihal1, Arnoud Boot, Eddy H van Roon
1Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Abstract:
Development of colorectal cancer (CRC) can occur both via gene mutations in tumor suppressor genes and oncogenes, as well as via epigenetic changes, including DNA methylation. Site-specific methylation in CRC regulates expression of tumor-associated genes. Right-sided colon tumors more frequently have BRAF (p.V600E) mutations and have higher methylation grades when compared to left-sided malignancies. The aim of this study was to identify DNA methylation changes associated with BRAF (p.V600E) mutation status. We performed methylation profiling of colon tumor DNA, isolated from frozen sections enriched for epithelial cells by macro-dissection, and from paired healthy tissue. Single gene analyses comparing BRAF (p.V600E) with BRAF wild type revealed MEIS1 as the most significant differentially methylated gene (log2 fold change: 0.89, false discovery rate-adjusted P-value 2.8*10(-9)). This finding was validated by methylation-specific PCR that was concordant with the microarray data. Additionally, validation in an independent cohort (n=228) showed a significant association between BRAF (p.V600E) and MEIS1 methylation (OR: 13.0, 95% CI: 5.2 - 33.0, P<0.0001). MEIS1 methylation was associated with decreased MEIS1 gene expression in both patient samples and CRC cell lines. The same was true for gene expression of a truncated form of MEIS1, MEIS1 D27 , which misses exon 8 and has a proposed tumor suppression function. To trace the origin of MEIS1 promoter methylation, 14 colorectal tumors were flow-sorted. Four out of eight BRAF (p.V600E) tumor epithelial fractions (50%) showed MEIS1 promoter methylation, as well as three out of eight BRAF (p.V600E) stromal fractions (38%). Only one out of six BRAF wild type showed MEIS1 promoter methylation in both the epithelial tumor and stromal fractions (17%). In conclusion, BRAF (p.V600E) colon tumors showed significant MEIS1 promoter methylation, which was associated with decreased MEIS1 gene expression.
Insights
Right-sided colorectal cancer (CRC) with BRAF (p.V600E) mutations frequently shows MEIS1 gene promoter methylation. This epigenetic change is linked to reduced MEIS1 gene expression, impacting tumor development.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Colorectal cancer (CRC) development involves gene mutations and epigenetic alterations like DNA methylation.
- Right-sided colon tumors often exhibit BRAF (p.V600E) mutations and higher methylation grades compared to left-sided tumors.
- Site-specific DNA methylation in CRC influences the expression of genes associated with tumorigenesis.
Purpose of the Study:
- To identify DNA methylation changes specifically associated with the BRAF (p.V600E) mutation status in colorectal cancer.
- To investigate the relationship between BRAF (p.V600E) mutation and MEIS1 gene methylation and expression.
Main Methods:
- DNA methylation profiling of colon tumor and paired healthy tissue using macro-dissection.
- Single gene analysis to compare methylation between BRAF (p.V600E) and BRAF wild-type tumors.
- Validation of findings using methylation-specific PCR and an independent patient cohort (n=228).
Main Results:
- MEIS1 was identified as the most significantly differentially methylated gene in BRAF (p.V600E) tumors.
- BRAF (p.V600E) mutation was strongly associated with MEIS1 methylation (OR: 13.0, P<0.0001) in an independent cohort.
- MEIS1 promoter methylation correlated with decreased MEIS1 and MEIS1 D27 gene expression in tumor samples and cell lines.
Conclusions:
- BRAF (p.V600E) positive colon tumors exhibit significant MEIS1 promoter methylation.
- This methylation is associated with reduced expression of MEIS1 and its truncated form, MEIS1 D27.
- MEIS1 methylation originates in both epithelial and stromal fractions of BRAF (p.V600E) tumors.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
MAPK Signaling Cascades
Master Transcription Regulators
Abnormal Proliferation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

